nach oben

Erschienen in:

01.09.2023 | News item

Marlex recalls digoxin 0.125mg and 0.25mg tablets due to label mix-up

Erschienen in: Reactions Weekly | Ausgabe 1/2023

Einloggen, um Zugang zu erhalten

Excerpt

The US FDA has published a company announcement from Marlex Pharmaceuticals advising that it has issued a voluntary nationwide recall of digoxin 0.125mg and 0.25mg tablets in USA due to a label mix-up. …

Marlex Pharmaceuticals, Inc. Issues Voluntary Nationwide Recall of Digoxin Tablets USP, 0.125mg and Digoxin Tablets USP, 0.25mg Due to Label Mix-Up Internet Document : 31 Aug 2023. Available from: URL: https://www.fda.gov/safety/recalls-market-withdrawals-safety-alerts/marlex-pharmaceuticals-inc-issues-voluntary-nationwide-recall-digoxin-tablets-usp-0125mg-and-digoxin

Titel: Marlex recalls digoxin 0.125mg and 0.25mg tablets due to label mix-up
Publikationsdatum: 01.09.2023
Verlag: Springer International Publishing
Erschienen in: Reactions Weekly / Ausgabe 1/2023
Print ISSN: 0114-9954
Elektronische ISSN: 1179-2051
DOI: https://doi.org/10.1007/s40278-023-45730-3

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Marlex recalls digoxin 0.125mg and 0.25mg tablets due to label mix-up

Excerpt

Live-Webinar "Urologie und Sexualmedizin in der Praxis"

Springer Medizin

Excerpt

Bitte loggen Sie sich ein, um Zugang zu diesem Inhalt zu erhalten

Weitere Artikel der Ausgabe 1/2023

Antibacterials

Propranolol

Alprazolam/fentanyl/oxycodone

Tozinameran

Bicalutamide/tacrolimus

Pembrolizumab